Related Experiment Video
Updated: Jan 25, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Sofiane Berrazouane1, Marc Boisvert1, Suzanne Salti2
1Division of Immune and Infectious Diseases, CHU de Québec-Université Laval Research Center, Quebec city, Canada.
Abstract:
Growing evidence indicates that cell adhesion to extracellular matrix (ECM) plays an important role in cancer chemoresistance. Leukemic T cells express several adhesion receptors of the β1 integrin subfamily with which they interact with ECM. However, the role of β1 integrins in chemoresistance of T-cell acute lymphoblastic leukemia (T-ALL) is still ill defined. In this study, we demonstrate that interactions of human T-ALL cell lines and primary blasts with three-dimensional matrices including Matrigel and collagen type I gel promote their resistance to doxorubicin via β1 integrin. The blockade of β1 integrin with a specific neutralizing antibody sensitized xenografted CEM leukemic cells to doxorubicin, diminished the leukemic burden in the bone marrow and resulted in the extension of animal survival. Mechanistically, Matrigel/β1 integrin interaction enhanced T-ALL chemoresistance by promoting doxorubicin efflux through the activation of the ABCC1 drug transporter. Finally, our findings showed that Matrigel/β1 interaction enhanced doxorubicin efflux and chemoresistance by activating the FAK-related proline-rich tyrosine kinase 2 (PYK2) as both PYK2 inhibitor and siRNA diminished the effect of Matrigel. Collectively, these results support the role of β1 integrin in T-ALL chemoresistance and suggest that the β1 integrin pathway can constitute a therapeutic target to avoid chemoresistance and relapsed-disease in human T-ALL.
Insights
Beta-1 integrins promote chemoresistance in T-cell acute lymphoblastic leukemia (T-ALL) by enhancing drug efflux. Blocking these integrins sensitizes leukemia cells to doxorubicin, suggesting a new therapeutic target for T-ALL.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Cell adhesion to the extracellular matrix (ECM) is increasingly recognized for its role in cancer chemoresistance.
- Beta-1 integrins are expressed by leukemic T cells and mediate interactions with the ECM, but their specific role in T-cell acute lymphoblastic leukemia (T-ALL) chemoresistance is unclear.
Purpose of the Study:
- To investigate the role of beta-1 integrins in chemoresistance of T-cell acute lymphoblastic leukemia (T-ALL).
- To explore the underlying mechanisms of beta-1 integrin-mediated chemoresistance and identify potential therapeutic targets.
Main Methods:
- Utilized human T-ALL cell lines and primary blasts cultured in 3D matrices (Matrigel, collagen type I gel).
- Employed beta-1 integrin neutralizing antibodies, doxorubicin treatment, and xenograft models in mice.
- Investigated doxorubicin efflux, ABCC1 drug transporter activation, and the involvement of FAK-related proline-rich tyrosine kinase 2 (PYK2) signaling.
Main Results:
- Interaction with 3D matrices via beta-1 integrin conferred doxorubicin resistance in T-ALL cells.
- Blocking beta-1 integrin sensitized T-ALL cells to doxorubicin, reduced leukemic burden, and improved survival in xenograft models.
- Beta-1 integrin interaction enhanced chemoresistance by promoting doxorubicin efflux via ABCC1 activation and PYK2 signaling.
Conclusions:
- Beta-1 integrin signaling plays a significant role in mediating chemoresistance in T-cell acute lymphoblastic leukemia.
- Targeting the beta-1 integrin pathway presents a promising therapeutic strategy to overcome doxorubicin resistance and prevent relapse in T-ALL.
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Neuromuscular Junction And Blockade
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity
Resistance

